Independent risk factors for lymph node metastasis in 2623 patients with Non-Small cell lung cancer

被引:8
|
作者
Xue, Xinying [1 ]
Zang, Xuelei [2 ]
Liu, Yuxia [3 ]
Lin, Dongliang [4 ]
Jiang, Tianjiao [5 ]
Gao, Jie [6 ]
Wu, Chongchong [7 ]
Ma, Xidong [8 ]
Deng, Hui [1 ]
Yu, Zhaofeng [9 ]
Pan, Lei [1 ]
Xue, Zhiqiang [10 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Resp & Crit Care, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Ctr Clin Lab Med, Beijing, Peoples R China
[3] Peking Union Med Coll Hosp, Dept Sci Res, Beijing, Peoples R China
[4] Qingdao Univ, Dept Pathol, Affiliated Hosp, Qingdao, Peoples R China
[5] Qingdao Univ, Dept Radiol, Affiliated Hosp, Qingdao, Peoples R China
[6] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Pathol, Beijing, Peoples R China
[7] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Radiol, Beijing, Peoples R China
[8] Weifang Med Univ, Dept Resp Med, Weifang, Peoples R China
[9] Weifang Med Univ, Weifang, Peoples R China
[10] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Thorac Surg, Beijing, Peoples R China
来源
SURGICAL ONCOLOGY-OXFORD | 2020年 / 34卷
关键词
Non-small cell lung cancer; Lymph node metastasis; Ki-67; Risk factors; 8TH EDITION; RESECTION; SURVIVAL; MARKERS;
D O I
10.1016/j.suronc.2020.05.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: this study attempts to identify the independent risk factors that can predict lymph node metastasis for the patients with non-small cell lung cancer (NSCLC), and guide doctor adoption of individualized treatment for such patients. Materials and methods: This study was approved by the Hospital's Ethics Committee and all patients had signed informed consent forms. We retrospectively reviewed NSCLC patients who had undergone surgical resection from December 2008 to December 2013. The statistical significance of evaluation variables and lymph node metastasis was determined with Pearson's Chi-square test. The risk factors of lymph node metastasis were determined through univariate and multivariate logistic regression analysis. And for the age and tumor diameter factors, optimal cutoff points were determined with a receiver operating characteristic analysis. Results: In the present study, a total of 2623 patients were included in the study, and 779 patients with lymph node metastasis. Three independent risk factors were identified: age, tumor diameter and Ki-67 index. We found that <65 years of age (Adjusted-OR:1.921), >=.2.85 cm of tumor diameter (Adjusted-OR:3.141), and 5% similar to 25% in Ki-67 group (Adjusted-OR:2.137), >= 25% (Adjusted-OR:3.341) were significant. Also we found that 307 patients with lymph node metastasis and the lymph node metastasis rate was 51.0%, when the age<65 years, Ki-67 index >= 25%, and the tumor diameter >= 2.85 cm. On the contrary, there were only 2 patients with lymph node metastasis, and the rate of lymph node metastasis was 5.1%. Conclusion: Identifying three independent risk factors that predict lymph node metastasis in non-small cell patients, Among NSCLC patients in whom all three predictors were identified, and over a half of the patients showed lymph node metastasis.
引用
收藏
页码:256 / 260
页数:5
相关论文
共 50 条
  • [21] Lymph node micrometastasis in non-small cell lung cancer
    Sun, Jiajing
    Wu, Sikai
    Jin, Zixian
    Ren, Sijia
    Cho, William C.
    Zhu, Chengchu
    Shen, Jianfei
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [22] A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients
    Xi, LQ
    Coello, MC
    Litle, VR
    Raja, S
    Gooding, WE
    Yousem, SA
    El-Hefnawy, T
    Landreneau, RJ
    Luketich, JD
    Godfrey, TE
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (08) : 2484 - 2491
  • [23] Apolipoprotein E is a predictive marker for assessing non-small cell lung cancer patients with lymph node metastasis
    An, Hyo Jung
    Koh, Hyun Min
    Song, Dae Hyun
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (10)
  • [24] Survival Rates of Patients with Non-Small Cell Lung Cancer Depending on Lymph Node Metastasis: A Focus on Saliva
    Bel'skaya, Lyudmila V.
    Sarf, Elena A.
    Kosenok, Victor K.
    [J]. DIAGNOSTICS, 2021, 11 (05)
  • [25] Is Topographic Classification Effective for Lymph Node Metastasis in Patients Affected by Non-Small Cell Lung Cancer? Response
    El-Sherief, Ahmed H.
    Lau, Charles T.
    Obuchowski, Nancy A.
    Mehta, Atul C.
    Rice, Thomas W.
    Blackstone, Eugene H.
    [J]. CHEST, 2017, 152 (06) : 1355 - 1356
  • [26] Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer
    Liu, H. B.
    Gu, X. L.
    Ma, X. Q.
    Lv, T. F.
    Wu, Y.
    Xiao, Y. Y.
    Yuan, D. M.
    Li, Y. F.
    Song, Y.
    [J]. NEOPLASMA, 2013, 60 (02) : 203 - 208
  • [27] Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis
    Ma Qian Li
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S570 - S570
  • [28] Dysregulation of microRNAs may lead to lymph node metastasis of non-small cell lung cancer
    Pastorkova, Z.
    Karda, J. S.
    Kolac, Z.
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S200 - S200
  • [29] Predictive Factors for Node Metastasis in Patients With Clinical Stage I Non-Small Cell Lung Cancer
    Cho, Sukki
    Song, In Hag
    Yang, Hee Chul
    Kim, Kwhanmien
    Jheon, Sanghoon
    [J]. ANNALS OF THORACIC SURGERY, 2013, 96 (01): : 239 - 245
  • [30] Risk Factors for Brain Metastasis in Patients with EGFR Mutant Non-Small Cell Lung Cancer
    Tozuka, T.
    Seike, M.
    Murata, Y.
    Sugano, T.
    Nakamichi, S.
    Minegishi, Y.
    Noro, R.
    Hirose, T.
    Kubota, K.
    Gemma, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S845 - S845